IS8094A - Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki - Google Patents

Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki

Info

Publication number
IS8094A
IS8094A IS8094A IS8094A IS8094A IS 8094 A IS8094 A IS 8094A IS 8094 A IS8094 A IS 8094A IS 8094 A IS8094 A IS 8094A IS 8094 A IS8094 A IS 8094A
Authority
IS
Iceland
Prior art keywords
dihydrocarbamepine
hydroxy
derivative
psychiatric illness
treat psychiatric
Prior art date
Application number
IS8094A
Other languages
English (en)
Inventor
Martenyi Ferenc
Schmutz Markus
Zechner Stefanie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8094A publication Critical patent/IS8094A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IS8094A 2003-04-02 2005-10-27 Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki IS8094A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45986403P 2003-04-02 2003-04-02
PCT/EP2004/003590 WO2004087168A1 (en) 2003-04-02 2004-04-01 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Publications (1)

Publication Number Publication Date
IS8094A true IS8094A (is) 2005-10-27

Family

ID=33131906

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8094A IS8094A (is) 2003-04-02 2005-10-27 Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki

Country Status (18)

Country Link
US (1) US20070010508A1 (is)
EP (1) EP1613329A1 (is)
JP (1) JP2006522064A (is)
KR (1) KR20050121235A (is)
CN (1) CN1767834A (is)
AU (1) AU2004226827B2 (is)
BR (1) BRPI0409151A (is)
CA (1) CA2520828A1 (is)
IS (1) IS8094A (is)
MA (1) MA27762A1 (is)
MX (1) MXPA05010614A (is)
NO (1) NO20055098L (is)
NZ (1) NZ542555A (is)
RU (1) RU2367440C2 (is)
TN (1) TNSN05246A1 (is)
TW (1) TW200502222A (is)
WO (1) WO2004087168A1 (is)
ZA (1) ZA200507742B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2607427C (en) * 2005-05-06 2015-11-24 Portela & C.A., S.A. Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
PT2380575E (pt) * 2005-05-06 2015-06-17 Bial Portela & Ca Sa Acetato de eslicarbazepina e utilização
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
GB2437078A (en) 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP2633868A1 (en) * 2008-02-13 2013-09-04 Targacept, Inc. Combination of alpha 7 nicotinic agonists and antipsychotics
SI2393828T1 (sl) 2009-02-03 2017-01-31 Amunix Operating Inc. Podaljšani rekombinantni polipetidi in sestavki, ki jih obsegajo
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US8680050B2 (en) 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CN102188432B (zh) * 2011-04-07 2012-05-23 江立富 一种用于防治癫痫的药物
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
US9896451B2 (en) 2013-09-06 2018-02-20 Nippon Soda Co., Ltd. Method for producing endo-9-azabicyclo[3.3.1]nonan-3-ol derivative
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE10036289A1 (de) 2000-07-26 2002-02-07 Bosch Gmbh Robert Elektronisch kommutierte elektrische Maschine, insbesondere Motor
EP1446383B1 (en) * 2001-11-12 2008-09-17 Novartis AG Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain

Also Published As

Publication number Publication date
CN1767834A (zh) 2006-05-03
RU2005133665A (ru) 2006-06-10
NO20055098L (no) 2005-12-22
AU2004226827B2 (en) 2008-04-03
CA2520828A1 (en) 2004-10-14
EP1613329A1 (en) 2006-01-11
WO2004087168A1 (en) 2004-10-14
NO20055098D0 (no) 2005-11-01
US20070010508A1 (en) 2007-01-11
RU2367440C2 (ru) 2009-09-20
JP2006522064A (ja) 2006-09-28
MXPA05010614A (es) 2005-11-23
TW200502222A (en) 2005-01-16
BRPI0409151A (pt) 2006-03-28
TNSN05246A1 (en) 2007-06-11
AU2004226827A1 (en) 2004-10-14
KR20050121235A (ko) 2005-12-26
ZA200507742B (en) 2008-07-30
NZ542555A (en) 2009-03-31
MA27762A1 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
CY2022001I2 (el) Παραγωγα του uk-2a
IS8371A (is) Notkun breyttra sýklósporína til að meðhöndla HCVsjúkdóma
IS7851A (is) 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar
EP1583997A4 (en) Photoresist DISTANCE
DE112004000372D2 (de) Destillationsverfahren
IS8023A (is) Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma
DK1687066T3 (da) Fremgangsmåder til immunmodulering
DK1706112T3 (da) Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom
DE50308694D1 (de) Bestrahlungsger t
DK1567112T3 (da) Thiazolidin-4-oner til at hæmme hYAK3-proteiner
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
NO20070297A (no) Brønnbehandling
IS8094A (is) Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki
DE60328978D1 (de) Isochinolinderivate als mao-b inhibitoren
DK1492934T3 (da) Dørenhed
PL371629A1 (pl) Sposób wytwarzania kombrestatyn
IS8470A (is) Notkun lífrænna efnasambanda
DE502004011589D1 (de) Silylierte carboxamide
IS8491A (is) Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir
ITMI20030150A1 (it) Processo per preparare fluoroalogenoeteri.
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
EP1616948A4 (en) THIOREDOXINMODIFIKATION
DE602004030793D1 (de) Asynchrones flimmerreduktionsverfahren
ATE339200T1 (de) Behandlung von hyperurikämie